Unity Biotechnology Inc. (UBX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Unity Biotechnology Inc. (UBX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.71

0.00 (0.00%)

At close: Jan 15, 2025, 3:59 PM

undefined% (undefined)

Bid	1.59
Market Cap	28.81M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.28
PE Ratio (ttm)	-1.34
Forward PE	n/a
Analyst	Buy

Ask	1.76
Volume	221,508
Avg. Volume (20D)	145,922
Open	1.73
Previous Close	1.71
Day's Range	1.56 - 1.77
52-Week Range	0.94 - 2.02
Beta	undefined

About UBX

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic dis...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date May 3, 2018

Employees 19

Stock Exchange NASDAQ

Ticker Symbol UBX

Website https://unitybiotechnology.com

Analyst Forecast

According to 2 analyst ratings, the average rating for UBX stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 309.36% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

5 days ago · Source

+34.59%

Unity Biotechnology shares are trading higher afte... Unlock content with Pro Subscription

News

5 months ago · zacks.com

UNITY Biotechnology (UBX) Upgraded to Buy: Here's What You Should Know

UNITY Biotechnology (UBX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

8 months ago · zacks.com

All You Need to Know About UNITY Biotechnology (UBX) Rating Upgrade to Buy

UNITY Biotechnology (UBX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 year ago · investorplace.com

Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks

Longevity stocks have started to come on many investors' radars. These companies come with the promise of stable returns over the long run as human life continues to stretch further ahead.